F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: the APACH1 study

Elske Quak, David Blanchard, Benjamin Houdu, Yannick Le Roux, Renaud Ciappuccini, Barbara Lireux, Dominique de Raucourt, Jean-Michel Grellard, Idlir Licaj, Stéphane Bardet, Yves Reznik, Bénédicte Clarisse, Nicolas Aide, Elske Quak, David Blanchard, Benjamin Houdu, Yannick Le Roux, Renaud Ciappuccini, Barbara Lireux, Dominique de Raucourt, Jean-Michel Grellard, Idlir Licaj, Stéphane Bardet, Yves Reznik, Bénédicte Clarisse, Nicolas Aide

Abstract

Purpose: To evaluate the sensitivity of F18-choline (FCH) PET/CT for parathyroid adenoma detection prior to surgery in patients with primary hyperparathyroidism and negative or inconclusive cervical ultrasound and Tc99m-sestaMIBI SPECT/CT.

Methods: We conducted a prospective bicentric study (NCT02432599). All patients underwent FCH PET/CT. The result was scored positive, inconclusive or negative. The number of uptakes and their sites were recorded. The FCH PET/CT result guided the surgical procedure (minimally invasive parathyroidectomy, bilateral cervical exploration, or other in case of multiple or ectopic foci). FCH PET/CT results were compared to the surgical and pathological findings and the follow-up.

Results: Twenty-five patients were included. Mean calcium and PTH levels prior to surgery were 2.76 ± 0.17 mmol/l and 94.8 ± 37.4 ng/l. Nineteen (76%) FCH PET/CTs were scored positive, 3 (12%) inconclusive and 3 (12%) negative, showing 21 cases of uniglandular disease, including 1 ectopic localization and 1 case of multiglandular (3 foci) disease. Mean lesion size was 13.1 ± 8.6 mm. Twenty-four patients underwent surgery. FCH PET/CT guided surgery in 22 (88%) patients, allowing for 17 minimally invasive parathyroidectomies, 1 bilateral cervical exploration for multifocality and 4 other surgical procedures. Two patients with negative FCH-PET/CT underwent bilateral cervical exploration. When dichotomizing the FCH PET/CT results, thereby classifying the inconclusive FCH PET/CT results as positive, the per lesion and per patient sensitivities were 91.3% (95%CI: 72.0-98.9) and 90.5% (95%CI: 69.6-98.8) and the corresponding positive predictive values were 87.5% (95%CI: 67.6-97.3) and 86.4% (95%CI: 65.1-97.1), respectively. Twenty-one (88%) patients were considered cured after surgery. Their mean calcium level after surgery was 2.36 ± 0.17 mmol/l.

Conclusions: Preoperative FCH PET/CT has a high sensitivity and positive predictive value for parathyroid adenoma detection in patients with primary hyperparathyroidism and negative or inconclusive conventional imaging results. Bilateral cervical exploration could be avoided in the majority (75%) of patients.

Keywords: F18-choline; MIBI SPECT/CT; Minimally invasive surgery; PET/CT; Parathyroid adenoma; Primary hyperparathyroidism.

Conflict of interest statement

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study (Ref. 2014–41, Comité de protection des personnes Nord-Ouest III).

Figures

Fig. 1
Fig. 1
Flow chart of patients through the study. MIP minimally invasive parathyroidectomy, BCE bilateral cervical exploration, UCE unilateral cervical exploration, AE adverse event, PTA parathyroid adenoma, PHPT primary hyperparathyroidism
Fig. 2
Fig. 2
Semi-quantitative analyses of the (a) PTA-to-muscle ratio (b) PTA-to-thyroid ratio and (c) noise level in the muscle background for the list-mode PET acquisitions reconstructed with an increment of 2 min
Fig. 3
Fig. 3
FCH PET/CT images of a 66-y-old male patient with PHPT and negative cervical ultrasound and MIBI SPECT/CT. (a) FCH PET maximum-intensity-projection, (b) FCH PET/CT fusion transverse slice, and (c) low-dose CT transverse slice, showing increased FCH uptake in a flat PTA in the left superior position (red arrow). Resection of a flat left superior PTA was performed by minimally invasive parathyroidectomy, leading to cure
Fig. 4
Fig. 4
MIBI SPECT/CT and FCH PET/CT images of a 68-y-old female patient with PHPT, an inconclusive cervical ultrasound report (dubious right inferior focus only visible on one plane) and a negative MIBI SPECT/CT. (a) MIBI SPECT maximum-intensity-projection, (c) MIBI SPECT/CT transverse slice, (b) FCH PET maximum-intensity-projection, and (d) FCH PET/CT transverse slice. The MIBI and FCH MIP images (a, b) did not show clear focal uptake in the lower neck. However, the FCH PET/CT transverse slice (d) showed increased FCH uptake in a small ectopic deep-laying left-sided PTA in the upper mediastinum, which was negative on MIBI SPECT/CT (c) (red arrows). Successful ectopic parathyroidectomy was performed, leading to cure

References

    1. Alexandrides TK, Kouloubi K, Vagenakis AG, Yarmenitis S, Spyridonidis T, Vassilakos P, et al. The value of scintigraphy and ultrasonography in the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism and concomitant thyroid disease. Hormones (Athens ) 2006;5:42–51. doi: 10.14310/horm.2002.11167.
    1. Bhansali A, Masoodi SR, Bhadada S, Mittal BR, Behra A, Singh P. Ultrasonography in detection of single and multiple abnormal parathyroid glands in primary hyperparathyroidism: comparison with radionuclide scintigraphy and surgery. Clin Endocrinol. 2006;65:340–345. doi: 10.1111/j.1365-2265.2006.02601.x.
    1. Cheung K, Wang TS, Farrokhyar F, Roman SA, Sosa JAA. Meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol. 2012;19:577–583. doi: 10.1245/s10434-011-1870-5.
    1. Lo CY, Lang BH, Chan WF, Kung AW, Lam KSA. Prospective evaluation of preoperative localization by technetium-99m sestamibi scintigraphy and ultrasonography in primary hyperparathyroidism. Am J Surg. 2007;193:155–159. doi: 10.1016/j.amjsurg.2006.04.020.
    1. Harari A, Mitmaker E, Grogan RH, Lee J, Shen W, Gosnell J, et al. Primary hyperparathyroidism patients with positive preoperative sestamibi scan and negative ultrasound are more likely to have posteriorly located upper gland adenomas (PLUGs) Ann Surg Oncol. 2011;18:1717–1722. doi: 10.1245/s10434-010-1493-2.
    1. Ciappuccini R, Morera J, Pascal P, Rame JP, Heutte N, Aide N, et al. Dual-phase 99mTc sestamibi scintigraphy with neck and thorax SPECT/CT in primary hyperparathyroidism: a single-institution experience. Clin Nucl Med. 2012;37:223–228. doi: 10.1097/RLU.0b013e31823362e5.
    1. Lavely WC, Goetze S, Friedman KP, Leal JP, Zhang Z, Garret-Mayer E, et al. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy. J Nucl Med. 2007;48:1084–1089. doi: 10.2967/jnumed.107.040428.
    1. Neumann DR, Obuchowski NA, Difilippo FP. Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism. J Nucl Med. 2008;49:2012–2017. doi: 10.2967/jnumed.108.054858.
    1. Udelsman R, Lin Z, Donovan P. The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg. 2011;253:585–591. doi: 10.1097/SLA.0b013e318208fed9.
    1. Quak E, Lheureux S, Reznik Y, Bardet S, Aide N. F18-choline, a novel PET tracer for parathyroid adenoma? J Clin Endocrinol Metab. 2013;98:3111–3112. doi: 10.1210/jc.2013-2084.
    1. Michaud L, Burgess A, Huchet V, Lefevre M, Tassart M, Ohnona J, et al. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism? J Clin Endocrinol Metab. 2014;99:4531–4536. doi: 10.1210/jc.2014-2821.
    1. Lezaic L, Rep S, Sever MJ, Kocjan T, Hocevar M, Fettich J. (1)(8)F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study. Eur J Nucl Med Mol Imaging. 2014;41:2083–2089. doi: 10.1007/s00259-014-2837-0.
    1. Michaud L, Balogova S, Burgess A, Ohnona J, Huchet V, Kerrou K, et al. A pilot comparison of 18F-fluorocholine PET/CT, Ultrasonography and 123I/99mTc-sestaMIBI dual-phase dual-isotope Scintigraphy in the preoperative localization of Hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism: influence of thyroid anomalies. Medicine (Baltimore) 2015;94:e1701. doi: 10.1097/MD.0000000000001701.
    1. Uusijarvi H, Nilsson LE, Bjartell A, Mattsson S. Biokinetics of 18F-choline studied in four prostate cancer patients. Radiat Prot Dosim. 2010;139:240–244. doi: 10.1093/rpd/ncq024.
    1. DeGrado TR, Reiman RE, Price DT, Wang S, Coleman RE. Pharmacokinetics and radiation dosimetry of 18F-fluorocholine. J Nucl Med. 2002;43:92–96.
    1. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, et al. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53:766–772. doi: 10.1373/clinchem.2006.077180.
    1. ICRP Managing patient dose in multi-detector computed tomography (MDCT). ICRP publication 102. Ann ICRP. 2007;37(1):1–80. doi: 10.1016/j.icrp.2007.09.001.
    1. ICRP Radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances. ICRP publication 128. Ann ICRP. 2015;44(2 suppl):7–321.
    1. Donner A, Zou G. Interval estimation for a difference between intraclass kappa statistics. Biometrics. 2002;58:209–215. doi: 10.1111/j.0006-341X.2002.00209.x.
    1. van der Vos CS, Koopman D, Rijnsdorp S, Arends AJ, Boellaard R, van Dalen JA, et al. Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET. Eur J Nucl Med Mol Imaging. 2017;44:4–16. doi: 10.1007/s00259-017-3727-z.
    1. Kluijfhout WP, Vorselaars WM, van den Berk SA, Vriens MR, Borel Rinkes IH, Valk GD, et al. Fluorine-18 fluorocholine PET-CT localizes hyperparathyroidism in patients with inconclusive conventional imaging: a multicenter study from the Netherlands. Nucl Med Commun. 2016;37:1246–1252. doi: 10.1097/MNM.0000000000000595.
    1. Hocevar M, Lezaic L, Rep S, Zaletel K, Kocjan T, Sever MJ, et al. Focused parathyroidectomy without intraoperative parathormone testing is safe after pre-operative localization with 18F-Fluorocholine PET/CT. Eur J Surg Oncol. 2017;43:133–137. doi: 10.1016/j.ejso.2016.09.016.
    1. Caldarella C, Treglia G, Isgro MA, Giordano A. Diagnostic performance of positron emission tomography using 11C-methionine in patients with suspected parathyroid adenoma: a meta-analysis. Endocrine. 2013;43:78–83. doi: 10.1007/s12020-012-9746-4.
    1. Kluijfhout WP, Pasternak JD, Drake FT, Beninato T, Gosnell JE, Shen WT, et al. Use of PET tracers for parathyroid localization: a systematic review and meta-analysis. Langenbeck’s Arch Surg. 2016;401:925–935. doi: 10.1007/s00423-016-1425-0.

Source: PubMed

3
Iratkozz fel